Progesterone Test · Blood

If you have ever wondered whether your body is actually ovulating each month, or whether your hormonal environment could support a pregnancy, this is the test that answers those questions directly. Progesterone rises sharply after ovulation and stays elevated throughout the second half of your cycle. When it does not rise, it means ovulation did not happen, regardless of how regular your period looks on the calendar.

Beyond ovulation, progesterone tells you about the health of your luteal phase, the roughly two-week window between ovulation and your next period. If this phase is too short or your progesterone too low, the uterine lining may not develop well enough to support implantation. For women undergoing fertility treatment, this number guides real-time clinical decisions. For women simply tracking their cycles, it offers a concrete answer where basal body temperature and period-tracking apps can only guess.

What Progesterone Does in Your Body

Progesterone is built from cholesterol. The main source is the corpus luteum, the temporary structure that forms in the ovary after an egg is released. If pregnancy occurs, the placenta eventually takes over production. The adrenal glands contribute small amounts in both women and men, but clinically meaningful levels in blood come from ovarian production.

In the uterus, progesterone transforms the lining from a growth phase into a secretory phase (a stage where the lining produces nutrients and becomes receptive to a fertilized egg). It also relaxes the muscular wall of the uterus and helps keep the cervix closed during pregnancy. These actions are carried out through two types of receptors inside cells, called PR-A and PR-B. When these receptors do not work properly, conditions like endometriosis, uterine fibroids, and recurrent pregnancy loss can develop.

Progesterone also acts in the brain. It is converted into a compound called allopregnanolone, which affects mood, anxiety, and sleep through the same brain signaling system targeted by sedative medications. This is why some women notice mood shifts, sleepiness, or anxiety changes in the second half of their cycle when progesterone is naturally elevated.

Fertility and Ovulation

The most common clinical reason to measure serum progesterone is to confirm that ovulation occurred. In the first half of the cycle (the follicular phase), progesterone stays very low, typically below 1 to 2 ng/mL. After ovulation, it rises to a peak in the mid-luteal phase, usually around day 21 of a 28-day cycle. A value above 3 to 5 ng/mL at this point is accepted as evidence that ovulation happened. In a study of 208 women with regular cycles who were having difficulty conceiving, a single well-timed mid-luteal progesterone measurement showed high agreement with ultrasound confirmation of ovulation.

For women undergoing frozen embryo transfer (FET), serum progesterone around the time of transfer has direct implications for success. A meta-analysis of 21 studies found that when progesterone was below roughly 10 ng/mL in women receiving vaginal progesterone support, ongoing pregnancy and live birth rates were about 47% higher in the group above that threshold, and miscarriage risk was about 38% lower. A separate multicentre study of 402 women identified 7.8 ng/mL as the 10th percentile, with women below that level having roughly 60% lower odds of live birth after adjustment for age, BMI, embryo quality, and other factors.

If you are going through fertility treatment and your progesterone comes back low before transfer, this is not necessarily a dead end. Research shows that adding supplemental progesterone (sometimes called "rescue" progesterone) at that point can bring outcomes back in line with women whose levels were adequate from the start.

Early Pregnancy Viability

When a woman presents with pain or bleeding in the first trimester and ultrasound cannot yet confirm whether the pregnancy is viable, a single serum progesterone measurement can be a useful triage tool. A meta-analysis of cohort studies found that at a cutoff of roughly 3 to 6 ng/mL, a low value predicted a non-viable pregnancy (miscarriage or ectopic) with about 75% sensitivity and 98% specificity. In emergency department patients with very early pregnancy hormone levels below 1,000 mIU/mL, a progesterone below 5 ng/mL identified abnormal pregnancies with 94% sensitivity and 100% specificity.

This does not replace ultrasound or serial pregnancy hormone tracking, but it adds a fast, inexpensive data point that can speed up decision-making when waiting days for a follow-up scan is stressful or clinically risky. A single progesterone measurement has been shown to be more sensitive than a 48-hour rise in pregnancy hormone levels for identifying abnormal pregnancies, potentially shortening the diagnostic window by about two days.

Progesterone and IVF Stimulation Cycles

During ovarian stimulation for IVF, progesterone is measured on the day of the trigger injection. If it rises prematurely, it can shift the uterine lining out of sync with the developing embryos, reducing implantation chances. A systematic review of over 60,000 IVF cycles found that in fresh transfer cycles, even modest elevations above 0.8 to 1.1 ng/mL on trigger day were associated with about 21% lower odds of pregnancy, with the effect growing as levels climbed. At levels above 1.5 ng/mL, one large single-centre analysis of over 4,000 cycles showed ongoing pregnancy rates dropping from about 31% to 19%.

This effect disappears in frozen-thawed and donor-recipient cycles, confirming that premature progesterone rise harms the lining's receptivity window, not the embryos themselves. When elevated progesterone is detected, many clinics now choose a "freeze-all" strategy, transferring embryos in a later, better-synchronized cycle.

Reference Ranges

Progesterone interpretation depends entirely on when in the menstrual cycle the blood is drawn. A value of 2 ng/mL is perfectly normal on day 5 of your cycle and deeply concerning on day 21. These ranges come from multiple clinical studies and vary by lab platform, so always compare your result to the reference range printed on your specific lab report.

These are clinical decision thresholds drawn from fertility and obstetric research, not population-wide "optimal" ranges for general health. No published data support specific progesterone targets for longevity, metabolic health, or disease prevention outside of reproductive contexts.

When Results Can Be Misleading

Progesterone has one of the highest within-person variability rates of any commonly measured hormone. In women, the day-to-day variation is roughly 50%, compared to about 13% in men. This means a single measurement can differ dramatically from a reading taken even 24 hours later in the same person during the same cycle phase. Timing your blood draw is far more important than most people realize.

• Cycle timing: Drawing blood on the wrong day is the single most common source of misleading results. A low value on day 18 of a 32-day cycle does not mean you are not ovulating; it may simply mean ovulation has not happened yet. Aim for roughly 7 days after suspected ovulation.
• Time of day: In ovarian stimulation cycles, progesterone dropped by roughly 44% from morning to evening on the same day. In natural FET cycles, mid-afternoon values were significantly lower than morning or evening readings. If possible, draw your blood in the morning and keep the timing consistent across repeated tests.
• Hormonal contraceptives: Combined oral contraceptives and progestin-only methods suppress ovarian progesterone production and can make readings uninterpretable for assessing natural ovulatory function. Stop hormonal contraception and allow at least one full natural cycle before testing for ovulation.
• Lab platform differences: Different lab platforms can give meaningfully different results for the same blood sample, especially at low concentrations below 1.5 ng/mL. Clinical decision thresholds developed on one platform may not apply to another. Always compare serial results from the same lab.